国际眼科纵览

• 综述 •    下一篇

原发性急性闭角型青光眼的发病率、危险因素及致盲率

林思耕  林舟桥  梁远波  瞿佳   

  1. 325027温州医科大学附属眼视光医院临床与流行病学研究中心(林思耕、梁远波、瞿佳);325699浙江省乐清市人民医院眼科(林舟桥)
  • 收稿日期:2018-04-09 出版日期:2018-04-22 发布日期:2018-05-04
  • 通讯作者: 梁远波,Email:yuanboliang@126.com
  • 基金资助:

    浙江省卫生高层次人才(2016025);浙江省科技惠民计划(2014HOIOO7)

Incidence, risk factors and blindness rate of acute primary angle-closure glaucoma

LIN Si-geng1, LIN Zhou-qiao2, LIANG Yuan-bo1, QU Jia1   

  1. 1. Research Center for Clinical and Epidemiology, The Eye Hospital of Wenzhou Medical University, Wenzhou 325027, China; 2. Department of Ophthalmology, the People's Hospital of Yueqing City, Yueqing  Zhejiang 325699, China
  • Received:2018-04-09 Online:2018-04-22 Published:2018-05-04
  • Supported by:

    Zhejiang Health High Level Talent Project (2016025); Zhejiang Science and Technology Benefit Project (2014HOIOO7)

摘要:

原发性闭角型青光眼(primary angle closure glaucoma,PACG)常见于亚洲,其中急性闭角型青光眼(acute primary angle-closure glaucoma,APACG)在亚洲的发病率高于欧美,而不同的分类、定义可能会导致不同的调查结果。APACG不仅与性别、年龄、人种等人口统计学因素相关,还与眼部解剖结构特征有一定的联系。APACG年发病率在欧美国家为2.0/10万~8.3/10万,在亚洲国家为10.4/10万~12.2 /10万。女性的年发病率多于男性,发病率随年龄的增高而上升。同时,PACG的致盲率高于原发性开角型青光眼,而且APACG的致盲与就诊时间的长短有关。探索如何通过一定的干预手段降低APACG的致盲率,对青光眼的防治具有重要意义。(国际眼科纵览, 2018,  42:  73-77)

Abstract:

Prevalence of primary angle closure glaucoma (PACG) is higher in Asia. The incidence of acute primary angle-closure glaucoma (APACG) in Asia is higher than in the Euro-American countries. These studies proved that APACG has a strong association with gender, age, race and ocular anatomy. The incidence in APACG is from 2.0/100000 to 8.3/100000 in Europe and America, and from 10.4/100000 to 12.2/100000 in Asian countries. The incidence in female were more than this in male, and the incidence increased with age. The prevalence of blindness in PACG was higher than that in primary open angle glaucoma. In addition, the blindness rate of APACG was related to duration of symptoms before presentation. Therefore, there is great clinical implication to explore the way to reduce the blindness caused by APACG.  (Int Rev Ophthalmol, 2018, 42: 73-77)